Detalles de la búsqueda
1.
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver Int
; 44(5): 1108-1125, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517286
2.
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
Br J Cancer
; 128(7): 1391-1399, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759721
3.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Br J Cancer
; 128(5): 877-885, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36482190
4.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.
Liver Int
; 43(8): 1803-1812, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452505
5.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636444
6.
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
Hepatol Res
; 52(12): 1050-1059, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35960789
7.
Intraoperative bowel perfusion quantification with hyperspectral imaging: a guidance tool for precision colorectal surgery.
Surg Endosc
; 36(11): 8520-8532, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35836033
8.
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
Liver Int
; 41(12): 2997-3008, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250737
9.
Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancer.
Future Oncol
; 17(14): 1749-1759, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33464133
10.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(18): 2315-2324, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33663264
11.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
12.
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
BMC Cancer
; 20(1): 683, 2020 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32698790
13.
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Oncologist
; 24(3): 385-393, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606884
14.
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program.
Oncologist
; 23(10): 1178-1187, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29739893
15.
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC.
Future Oncol
; 14(14): 1339-1346, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846100
16.
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
BMC Cancer
; 17(1): 408, 2017 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28599628
17.
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study.
J Clin Oncol
; : JCO2302728, 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38865678
18.
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
Target Oncol
; 19(3): 359-370, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38691295
19.
[Radically resected pancreatic cancer and adjuvant treatment. A review of the literature]. / Carcinoma del pancreas resecato radicalmente e terapia adiuvante. Revisione della letteratura.
Recenti Prog Med
; 104(2): 80-5, 2013 Feb.
Artículo
en Italiano
| MEDLINE | ID: mdl-23535964
20.
Impact of Oocyte Extract Supplement on Quality of Life after Hepatectomy for Liver Tumours: A Prospective, Multicentre, Double-Blind Randomized Clinical Trial.
Cancers (Basel)
; 15(10)2023 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345146